Global Gynecomastia Procedures Market Size, Share, and COVID-19 Impact Analysis, By Age Group (18-40, Above 40), By Procedure Type (Liposuction, Excision), By End-Use (Hospitals, Cosmetic Surgery Center), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033
Industry: HealthcareGlobal Gynecomastia Procedures Market Insights Forecasts to 2033
- The Global Gynecomastia Procedures Market Size was valued at USD 876 Million in 2023.
- The Market Size is Growing at a CAGR of 8.05% from 2023 to 2033.
- The Worldwide Gynecomastia Procedures Market Size is expected to reach USD 1900 Million by 2033.
- Asia-Pacific is expected to grow the fastest during the forecast period.
Get more details on this report -
The Global Gynecomastia Procedures Market size is Anticipated to Exceed USD 1900 Million by 2033, growing at a CAGR of 8.05% from 2023 to 2033.
Market Overview
Gynecomastia procedures are surgical procedures used to treat gynecomastia, a condition in which males develop excessive breast tissue. This can be caused by hormonal imbalances, certain medications, or underlying health problems. The techniques used to restore a more masculine chest appearance include liposuction, glandular tissue excision, or a combination of both of them. Rising awareness of cosmetic and aesthetic procedures, and the reduced stigma associated with seeking such treatments, has prompted more men to investigate options for treating gynecomastia. Furthermore, the media, celebrity culture, and body image awareness have all contributed to increased demand for gynecomastia procedures, particularly among younger demographics. As medical specialists develop expertise in gynecomastia procedures, patients can access high-quality care and customized therapies. The market also reflects a growing preference for combination procedures, in which liposuction and glandular tissue removal are frequently performed simultaneously to achieve comprehensive and natural-looking results. This approach is designed for clients who want a comprehensive solution to excess fat and glandular overgrowth.
Report Coverage
This research report categorizes the market for the global gynecomastia procedures market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global gynecomastia procedures market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global gynecomastia procedures market.
Global Gynecomastia Procedures Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2023 |
Market Size in 2023: | USD 876 Million |
Forecast Period: | 2023-2033 |
Forecast Period CAGR 2023-2033 : | gynecomastia-procedures-market |
2033 Value Projection: | USD 1900 Million |
Historical Data for: | 2019-2022 |
No. of Pages: | 200 |
Tables, Charts & Figures: | 115 |
Segments covered: | By Age Group, By Procedure Type, By End-Use, By Region |
Companies covered:: | Cadila Pharmaceuticals Ltd, Biochem Pharmaceutical Industries Ltd, Dr. Reddy's Laboratories Ltd, Micro Nova Pharmaceuticals Ltd, Kee Pharma Ltd, Sun Pharmaceuticals Industries Ltd, Zydus Cadila Healthcare Ltd, Allergan (AbbVie Inc.), Sientra, Inc., GC Aesthetics, POLYTECH Health & Aesthetics GmbH, Mentor Worldwide LLC (Johnson & Johnson), and other key companies. |
Pitfalls & Challenges: | Covid-19 Empact,Challenges,Growth, Analysis. |
Get more details on this report -
Driving Factors
Rising awareness and acceptance contribute significantly to the growth of the global gynecomastia procedures market. Additionally, developments in surgical techniques, such as the use of ultrasound-assisted liposuction and tissue excision, contribute to market growth by providing safer and more effective treatment options. Individuals' growing disposable income, particularly in developed countries, makes cosmetic procedures more affordable. This financial capability contributes to the global gynecomastia procedures market growth. Furthermore, medical tourism has a positive effect on the global gynecomastia procedures market by expanding the geographical reach of patients seeking treatment, encouraging cross-border collaborations among healthcare providers, and contributing to global gynecomastia procedures market growth through increased patient demand for gynecomastia interventions.
Restraining Factors
Patient safety is a major concern in the gynecomastia procedures market. Invasive procedures, if not performed by qualified professionals, can pose risks, focusing on the importance of stringent safety measures. Affordability and accessibility remain obstacles, especially in areas where cosmetic procedures are not covered by insurance. This might limit the global gynecomastia procedures market's reach to a specific demographic.
Market Segmentation
The Global Gynecomastia Procedures Market share is classified into age group, procedure type, and end-use.
- The above 40 segment is expected to grow fastest in the global gynecomastia procedures market during the forecast period.
The global gynecomastia procedures market is categorized by age group into 18-40, above 40. Among these, the above 40 segment is expected to grow fastest in the global gynecomastia procedures market during the forecast period. This is due to the aging process, which causes hormonal fluctuations, the gradual impact of risk factors over time, such as medication use, common health conditions among older adults, and increased financial resources. Reduced testosterone levels and an increased proportion of body fat promote breast tissue growth, making older people more likely to develop gynecomastia.
- The excision segment is expected to hold a significant share of the global gynecomastia procedures market during the forecast period.
Based on procedure type, the global gynecomastia procedures market is divided into liposuction and excision. Among these, the excision segment is expected to hold a significant share of the global gynecomastia procedures market during the forecast period. The growing acceptance of excision surgery can be attributed to innovations in surgical techniques for removing glandular tissue. Surgeons now have access to more refined and precise methods for effectively removing glandular tissue with minimal scarring. This has been reflected in a rise in the use of these advanced techniques.
- The cosmetic surgery center segment is expected to grow fastest in the global gynecomastia procedures market during the forecast period.
The global gynecomastia procedures market is categorized by end-use in hospitals and cosmetic surgery centers. Among these, the cosmetic surgery center segment is expected to grow fastest in the global gynecomastia procedures market during the forecast period. Cosmetic surgery centers specialize in a variety of aesthetic procedures, including body contouring and breast surgery. Furthermore, cosmetic surgery centers are more concerned with aesthetic outcomes since they understand the impact of gynecomastia on a patient's self-confidence and body image and strive to provide more natural and balanced results, which contributes to the growing demand for cosmetic surgery centers.
Regional Segment Analysis of the Global Gynecomastia Procedures Market
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Rest of APAC)
- South America (Brazil and the Rest of South America)
- The Middle East and Africa (UAE, South Africa, Rest of MEA)
North America is anticipated to hold the largest share of the global gynecomastia procedures market over the predicted timeframe.
North America is projected to hold the largest share of the global gynecomastia procedures market over the predicted years. Advanced healthcare infrastructure, a stringent regulatory environment, an emphasis on patient safety and care quality, and the presence of key players all contribute to regional growth. Furthermore, the lower cost of healthcare services and relatively higher disposable incomes allow clients to pursue gynecomastia treatments more easily. The North American market is extremely competitive, with numerous specialized medical facilities and healthcare providers offering a diverse range of treatment options. This competition supports innovation and ensures a high standard of care, reinforcing the region's market dominance.
Asia-Pacific is expected to grow fastest in the global gynecomastia procedures market during the forecast period. As knowledge about gynecomastia and its treatment options grows in the Asia Pacific region, the stigma associated with it is gradually fading, resulting in greater acceptance and demand for treatments. Furthermore, the Asia Pacific region has experienced significant economic growth in recent years, resulting in a rise in disposable income among the population, which has boosted regional gynecomastia procedures market growth.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved in the global gynecomastia procedures along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Cadila Pharmaceuticals Ltd
- Biochem Pharmaceutical Industries Ltd
- Dr. Reddy's Laboratories Ltd
- Micro Nova Pharmaceuticals Ltd
- Kee Pharma Ltd
- Sun Pharmaceuticals Industries Ltd
- Zydus Cadila Healthcare Ltd
- Allergan (AbbVie Inc.)
- Sientra, Inc.
- GC Aesthetics
- POLYTECH Health & Aesthetics GmbH
- Mentor Worldwide LLC (Johnson & Johnson)
- Others
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Developments
- In March 2023, Cadila Pharma has revealed plans to invest a significant Rs 1,000 crore in expanding its current facilities in Gujarat.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the Global Gynecomastia Procedures Market based on the below-mentioned segments:
Global Gynecomastia Procedures Market, By Age Group
- 18-40
- Above 40
Global Gynecomastia Procedures Market, By Procedure Type
- Liposuction
- Excision
Global Gynecomastia Procedures Market, By End Use
- Hospitals
- Cosmetic Surgery Center
Global Gynecomastia Procedures Market, By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- Uk
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
Need help to buy this report?